Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion description "[Synaptojanin-1 and C21orf2 were increased in DS, but others were comparable between DS and controls, suggesting that the DS phenotype cannot be simply explained by gene dosage effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion evidence source_evidence_literature NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion SIO_000772 12624744 NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion wasDerivedFrom befree-20140225 NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion wasGeneratedBy ECO_0000203 NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.